Arrowhead Pharmaceuticals Stock Forecast - Naive Prediction
| ARWR Stock | USD 65.58 1.33 1.99% |
Arrowhead Stock outlook is based on your current time horizon. Although Arrowhead Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Arrowhead Pharmaceuticals' systematic risk associated with finding meaningful patterns of Arrowhead Pharmaceuticals fundamentals over time.
As of today, The RSI of Arrowhead Pharmaceuticals' share price is at 54. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Arrowhead Pharmaceuticals, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.098 | EPS Estimate Next Quarter 0.045 | EPS Estimate Current Year (3.31) | EPS Estimate Next Year (4.39) | Wall Street Target Price 81.9167 |
Using Arrowhead Pharmaceuticals hype-based prediction, you can estimate the value of Arrowhead Pharmaceuticals from the perspective of Arrowhead Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Arrowhead Pharmaceuticals using Arrowhead Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Arrowhead using crowd psychology based on the activity and movement of Arrowhead Pharmaceuticals' stock price.
Arrowhead Pharmaceuticals Short Interest
An investor who is long Arrowhead Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Arrowhead Pharmaceuticals and may potentially protect profits, hedge Arrowhead Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 32.4097 | Short Percent 0.1052 | Short Ratio 4.02 | Shares Short Prior Month 9.6 M | 50 Day MA 61.5586 |
Arrowhead Relative Strength Index
The Naive Prediction forecasted value of Arrowhead Pharmaceuticals on the next trading day is expected to be 69.14 with a mean absolute deviation of 2.38 and the sum of the absolute errors of 147.63.Arrowhead Pharmaceuticals Hype to Price Pattern
Investor biases related to Arrowhead Pharmaceuticals' public news can be used to forecast risks associated with an investment in Arrowhead. The trend in average sentiment can be used to explain how an investor holding Arrowhead can time the market purely based on public headlines and social activities around Arrowhead Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Arrowhead Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Arrowhead Pharmaceuticals.
Arrowhead Pharmaceuticals Implied Volatility | 1.25 |
Arrowhead Pharmaceuticals' implied volatility exposes the market's sentiment of Arrowhead Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Arrowhead Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Arrowhead Pharmaceuticals stock will not fluctuate a lot when Arrowhead Pharmaceuticals' options are near their expiration.
The Naive Prediction forecasted value of Arrowhead Pharmaceuticals on the next trading day is expected to be 69.14 with a mean absolute deviation of 2.38 and the sum of the absolute errors of 147.63. Arrowhead Pharmaceuticals after-hype prediction price | USD 65.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Arrowhead | Build AI portfolio with Arrowhead Stock |
Prediction based on Rule 16 of the current Arrowhead contract
Based on the Rule 16, the options market is currently suggesting that Arrowhead Pharmaceuticals will have an average daily up or down price movement of about 0.0781% per day over the life of the 2026-03-20 option contract. With Arrowhead Pharmaceuticals trading at USD 65.58, that is roughly USD 0.0512 . If you think that the market is fully incorporating Arrowhead Pharmaceuticals' daily price movement you should consider acquiring Arrowhead Pharmaceuticals options at the current volatility level of 1.25%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Arrowhead Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Arrowhead Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Arrowhead Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Arrowhead Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Arrowhead Pharmaceuticals' open interest, investors have to compare it to Arrowhead Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Arrowhead Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Arrowhead. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Arrowhead Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Arrowhead price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arrowhead using various technical indicators. When you analyze Arrowhead charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Arrowhead Pharmaceuticals Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Arrowhead Pharmaceuticals' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 1999-12-31 | Previous Quarter 129.8 M | Current Value 88.7 M | Quarterly Volatility 85.1 M |
Arrowhead Pharmaceuticals Naive Prediction Price Forecast For the 30th of January
Given 90 days horizon, the Naive Prediction forecasted value of Arrowhead Pharmaceuticals on the next trading day is expected to be 69.14 with a mean absolute deviation of 2.38, mean absolute percentage error of 9.13, and the sum of the absolute errors of 147.63.Please note that although there have been many attempts to predict Arrowhead Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Arrowhead Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Arrowhead Pharmaceuticals Stock Forecast Pattern
| Backtest Arrowhead Pharmaceuticals | Arrowhead Pharmaceuticals Price Prediction | Buy or Sell Advice |
Arrowhead Pharmaceuticals Forecasted Value
In the context of forecasting Arrowhead Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Arrowhead Pharmaceuticals' downside and upside margins for the forecasting period are 63.93 and 74.36, respectively. We have considered Arrowhead Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Arrowhead Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Arrowhead Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 122.16 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 2.3812 |
| MAPE | Mean absolute percentage error | 0.0456 |
| SAE | Sum of the absolute errors | 147.634 |
Predictive Modules for Arrowhead Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arrowhead Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arrowhead Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arrowhead Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Arrowhead Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Arrowhead Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Arrowhead Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Arrowhead Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Arrowhead Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Arrowhead Pharmaceuticals' historical news coverage. Arrowhead Pharmaceuticals' after-hype downside and upside margins for the prediction period are 60.41 and 70.75, respectively. We have considered Arrowhead Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Arrowhead Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Arrowhead Pharmaceuticals is based on 3 months time horizon.
Arrowhead Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Arrowhead Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arrowhead Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Arrowhead Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.86 | 5.22 | 3.11 | 1.65 | 4 Events / Month | 7 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
65.58 | 65.58 | 0.00 |
|
Arrowhead Pharmaceuticals Hype Timeline
Arrowhead Pharmaceuticals is presently traded for 65.58. The entity has historical hype elasticity of -3.11, and average elasticity to hype of competition of -1.65. Arrowhead is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 144.2%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.86%. %. The volatility of related hype on Arrowhead Pharmaceuticals is about 272.58%, with the expected price after the next announcement by competition of 63.93. About 84.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 482.39. Arrowhead Pharmaceuticals recorded a loss per share of 0.01. The entity last dividend was issued on the 29th of October 2010. The firm had 1:10 split on the 17th of November 2011. Given the investment horizon of 90 days the next anticipated press release will be in about 4 days. Check out Historical Fundamental Analysis of Arrowhead Pharmaceuticals to cross-verify your projections.Arrowhead Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Arrowhead Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Arrowhead Pharmaceuticals' future price movements. Getting to know how Arrowhead Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Arrowhead Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PCVX | Vaxcyte | 0.82 | 12 per month | 2.47 | 0.09 | 6.38 | (3.46) | 15.14 | |
| CRSP | Crispr Therapeutics AG | (3.40) | 14 per month | 0.00 | (0.10) | 5.31 | (5.12) | 19.81 | |
| PTCT | PTC Therapeutics | (0.30) | 9 per month | 2.09 | 0.06 | 3.88 | (3.49) | 13.88 | |
| ACLX | Arcellx | (1.05) | 9 per month | 0.00 | (0.1) | 4.75 | (4.57) | 22.18 | |
| KRYS | Krystal Biotech | (3.62) | 18 per month | 1.08 | 0.24 | 4.46 | (2.43) | 10.86 | |
| TGTX | TG Therapeutics | (3.62) | 20 per month | 0.00 | (0.08) | 3.96 | (3.85) | 11.58 | |
| ALKS | Alkermes Plc | 0.36 | 12 per month | 2.01 | 0.06 | 3.82 | (2.30) | 11.41 | |
| AXSM | Axsome Therapeutics | (3.62) | 11 per month | 1.20 | 0.16 | 4.20 | (2.36) | 26.78 | |
| MTSR | Metsera Common Stock | (0.13) | 8 per month | 2.40 | 0.17 | 14.25 | (4.09) | 75.60 | |
| KYMR | Kymera Therapeutics | (4.59) | 11 per month | 2.65 | 0.07 | 4.40 | (4.46) | 49.42 |
Other Forecasting Options for Arrowhead Pharmaceuticals
For every potential investor in Arrowhead, whether a beginner or expert, Arrowhead Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Arrowhead Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Arrowhead. Basic forecasting techniques help filter out the noise by identifying Arrowhead Pharmaceuticals' price trends.Arrowhead Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arrowhead Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Arrowhead Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arrowhead Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Arrowhead Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Arrowhead Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arrowhead Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Arrowhead Pharmaceuticals stock market strength indicators, traders can identify Arrowhead Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 62844.31 | |||
| Daily Balance Of Power | (0.65) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 66.5 | |||
| Day Typical Price | 66.19 | |||
| Price Action Indicator | (1.59) | |||
| Period Momentum Indicator | (1.33) | |||
| Relative Strength Index | 54.76 |
Arrowhead Pharmaceuticals Risk Indicators
The analysis of Arrowhead Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Arrowhead Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arrowhead stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.39 | |||
| Semi Deviation | 2.89 | |||
| Standard Deviation | 5.01 | |||
| Variance | 25.14 | |||
| Downside Variance | 13.96 | |||
| Semi Variance | 8.35 | |||
| Expected Short fall | (3.71) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Arrowhead Pharmaceuticals
The number of cover stories for Arrowhead Pharmaceuticals depends on current market conditions and Arrowhead Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Arrowhead Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Arrowhead Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Arrowhead Pharmaceuticals Short Properties
Arrowhead Pharmaceuticals' future price predictability will typically decrease when Arrowhead Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Arrowhead Pharmaceuticals often depends not only on the future outlook of the potential Arrowhead Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arrowhead Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 133.8 M | |
| Cash And Short Term Investments | 919.4 M |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.